Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00812227 · ClinicalTrials.gov registry record · NA

Neural Correlates of Psychodynamic Psychotherapy for Depression

A NA study of Major Depressive Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT00812227 is a NA study of Major Depressive Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00812227, a NA study of Major Depressive Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see whether we can predict which patients with depression will get better when we treat them with psychodynamic psychotherapy. We will use neuroimaging (a method of looking at brain activity) in this study. We want to see whether there are changes in the brains of patients receiving this type of therapy. We hypothesize that these changes may predict how well certain parts of the psychotherapy treatment process works.

Conditions Studied

Interventions

  • BEHAVIORAL Psychodynamic Psychotherapy

Study Locations (1)

Massachusetts

  • Depression Clinical and Research Program - Boston

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2008-08
Est. Completion 2013-02
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00812227

The ClinicalTrials.gov registry entry for NCT00812227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (91% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Psychodynamic Psychotherapy is the first listed.

NCT00812227 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00812227 about?

NCT00812227 is a clinical study titled "Neural Correlates of Psychodynamic Psychotherapy for Depression". The purpose of this study is to see whether we can predict which patients with depression will get better when we treat them with psychodynamic psychotherapy. We will use neuroimaging (a method of looking at brain activity) in this study. We want to see whether there are changes in the brains of pat...

What is the current status of trial NCT00812227?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2008-08. Estimated completion is 2013-02.

What conditions does trial NCT00812227 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT00812227?

The interventions under investigation include: Psychodynamic Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00812227?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00812227 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.